Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124150003 | 12415000 | 3 | F | 20151228 | 20160718 | 20160530 | 20160721 | EXP | AU-ROCHE-1765670 | ROCHE | 91.08 | YR | F | Y | 64.00000 | KG | 20160721 | MD | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124150003 | 12415000 | 1 | PS | LUCENTIS | RANIBIZUMAB | 1 | Intraocular | EVERY 8 TO 10 WEEKS | 125156 | .5 | MG | SOLUTION FOR INJECTION | |||||||
| 124150003 | 12415000 | 2 | SS | LUCENTIS | RANIBIZUMAB | 1 | Intraocular | 0.5 MG, UNK | 125156 | .5 | MG | SOLUTION FOR INJECTION | |||||||
| 124150003 | 12415000 | 3 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 100 MG, UNK | 0 | 100 | MG | ||||||||
| 124150003 | 12415000 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 40 MG, UNK | 0 | 40 | MG | ||||||||
| 124150003 | 12415000 | 5 | C | DIAMICRON MR | GLICLAZIDE | 1 | Oral | 60 MG, UNK | 0 | 60 | MG | ||||||||
| 124150003 | 12415000 | 6 | C | MINAX | METAMIZOLE | 1 | Oral | 50 MG, BID | 0 | 50 | MG | BID | |||||||
| 124150003 | 12415000 | 7 | C | PERINDOPRIL ERBUMINE. | PERINDOPRIL ERBUMINE | 1 | Oral | 0 | |||||||||||
| 124150003 | 12415000 | 8 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, UNK | 0 | 75 | MG | ||||||||
| 124150003 | 12415000 | 9 | C | UREX | METHENAMINE HIPPURATE | 1 | Oral | 20 MG, UNK | 0 | 20 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124150003 | 12415000 | 1 | Neovascular age-related macular degeneration |
| 124150003 | 12415000 | 3 | Myocardial ischaemia |
| 124150003 | 12415000 | 4 | Myocardial ischaemia |
| 124150003 | 12415000 | 5 | Type 2 diabetes mellitus |
| 124150003 | 12415000 | 6 | Myocardial ischaemia |
| 124150003 | 12415000 | 7 | Hypertension |
| 124150003 | 12415000 | 8 | Myocardial ischaemia |
| 124150003 | 12415000 | 9 | Myocardial ischaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124150003 | 12415000 | DE |
| 124150003 | 12415000 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124150003 | 12415000 | Acute myocardial infarction | |
| 124150003 | 12415000 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124150003 | 12415000 | 1 | 20151021 | 20151021 | 0 | |
| 124150003 | 12415000 | 2 | 20160523 | 20160523 | 0 |